COVID-19 Funding Opportunities
The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.
Internal application deadline: October 22, 2020
The foundation seeks to identify outstanding inventors and innovators who harness science and technology to enhance the conduct of scientific research, strengthen environmental conservation, or improve the experience and outcomes of patient care. The Moore Inventor Fellows program focuses on supporting scientist-inventors at a critical stage of research to capture opportunities that otherwise might be missed. The scope of this call is intentionally wide: proposed projects should be broadly within the program areas of foundation interest (science, environmental conservation and patient care). The exception is for nominees proposing ideas and inventions that target patient care. Within this realm, the foundation seeks overlap with its current emphasis on improving the experience and outcomes of patients, including solutions in the areas of diagnostic excellence, medication safety in the community and community-based serious illness care.
Internal Nomination Process
Internal Application Deadline: October 26, 2020
The Major Research Instrumentation (MRI) Program
serves to increase access to multi-user scientific and engineering instrumentation
for research and research training in our Nation's institutions of higher
education and not-for-profit scientific/engineering research organizations.
An MRI award supports the acquisition or development of a multi-user
research instrument that is, in general, too costly and/or not appropriate
for support through other NSF programs. MRI provides support to acquire
critical research instrumentation without which advances in fundamental
science and engineering research may not otherwise occur. MRI also provides
support to develop next-generation research instruments that open new
opportunities to advance the frontiers in science and engineering research.
Additionally, an MRI award is expected to enhance research training
of students who will become the next generation of instrument users,
designers and builders.
Any MRI proposal may
request support for either the acquisition or development of a research
Eligibility & Requirements
Internal Nomination Process
Application Deadline: November 9, 2020
The grant is offered university-wide. We encourage cross-discipline and cross-school collaborative research. Any full-time faculty person from within Johns Hopkins University (JHU), including the schools of Medicine, Public Health, Nursing, Engineering, Business, Applied Physics Lab, and Arts/Sciences may act as PI. These Discovery Program grants are possible through the generous support of Sherrilyn Fisher.
Contact 443-287-4840 or firstname.lastname@example.org
No application deadline
The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.
The ability to image alpha-synuclein deposition
in the brain would be a game-changing achievement for the Parkinson's
disease (PD) field. The accumulation of aggregated alpha-synuclein is
a pathological hallmark of PD and a priority target for drug development
given its hypothesized contribution to neurodegeneration. In vivo imaging
of alpha-synuclein pathology could be useful as a biomarker of the presence
of disease and disease progression and as a pharmacodynamic tool for
drug development. With this prize, the Foundation seeks to attract research
teams and accelerate momentum to speed the development of such a tracer.
Contestants: Anyone is eligible for
the prize who agrees to all contest rules. Contestants may be MJFF funded
or not and can be from either academia or industry.
Criteria for winning: The winning contestant
must demonstrate that the radiotracer binds with relatively high selectivity
to alpha-synuclein according to pre-specified criteria and must demonstrate
proof-of-concept in human subjects, including people with Parkinson's
disease and/or another synucleinopathy. See below for more details on
Timeline: There is no deadline
for submissions. The $2 million award will be issued to the first
contestant who submits compelling evidence of a viable selective tracer
and agrees to its widespread use. If no award is given by mid-2018,
The Michael J. Fox Foundation will evaluate the state of the field and
utility of such a prize.